Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Hepatitis C in the United States.

Holmberg SD, Spradling PR, Moorman AC, Denniston MM.

N Engl J Med. 2013 May 16;368(20):1859-61. doi: 10.1056/NEJMp1302973. No abstract available.

PMID:
23675657
2.

[Treatment of chronic hepatitis C].

Fehér J, Lengyel G.

Orv Hetil. 2004 May 16;145(20):1065-7. Review. Hungarian. No abstract available.

PMID:
15202329
3.

Highly sensitive hepatitis C virus RNA detection assays for decision of treatment (dis)continuation in patients with chronic hepatitis C.

Mihm U, Hofmann WP, Kronenberger B, Wagner Mv, Zeuzem S, Sarrazin C.

J Hepatol. 2005 Apr;42(4):605-6. Epub 2004 Nov 26. No abstract available.

PMID:
15763349
4.

[Hepatitis C in Egypt, a iatrogenic epidemic].

Vrolijk JM, Schalm SW.

Ned Tijdschr Geneeskd. 2000 Dec 2;144(49):2378. Dutch. No abstract available.

PMID:
11129975
5.

[Quantification of hepatitis C virus RNA in serum].

Kawai S, Yokosuka O.

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):426-9. Japanese. No abstract available.

PMID:
15359836
6.

Viral response guided therapy for hepatitis C in the approaching era of direct acting anti-viral agents.

Berzsenyi MD, Roberts SK.

J Gastroenterol Hepatol. 2010 Apr;25(4):655-6. doi: 10.1111/j.1440-1746.2010.06283.x. No abstract available.

PMID:
20492322
7.

Making the best of a bad situation: early chronic nosocomial HCV infection.

Santos C, Herrine SK.

Dig Dis Sci. 2010 Jun;55(6):1509-11. doi: 10.1007/s10620-010-1283-5. Epub 2010 May 18. No abstract available.

PMID:
20480237
8.

Pegylated interferon treatment in HCV genotype 2 and 3 patients refractory to conventional interferon.

Aziz S.

J Coll Physicians Surg Pak. 2012 Oct;22(10):615-6. doi: 10.2012/JCPSP.615616. No abstract available.

PMID:
23058141
9.

Hepatitis C virus: five-year follow-up of patients with sustained virological response.

Urquijo JJ, Diago M.

Rev Esp Enferm Dig. 2011 Feb;103(2):53-5. No abstract available.

10.

Diagnostic testing for hepatitis C.

Carithers RL Jr, Marquardt A, Gretch DR.

Semin Liver Dis. 2000;20(2):159-71. Review.

PMID:
10946421
11.

Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus.

Elsharkawy AM.

Aliment Pharmacol Ther. 2014 Mar;39(5):543-4. doi: 10.1111/apt.12610. No abstract available.

12.

Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus - authors' reply.

Maasoumy B, Wedemeyer H.

Aliment Pharmacol Ther. 2014 Mar;39(5):544-5. doi: 10.1111/apt.12642. No abstract available.

13.
14.

Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection.

Lagging M, Alsiö A, Langeland N, Pedersen C, Färkkilä M, Buhl MR, Mørch K, Hellstrand K, Norkrans G.

Hepatology. 2011 Mar;53(3):1067-8. doi: 10.1002/hep.23962. Epub 2010 Dec 28. No abstract available.

PMID:
21374685
15.

[Hepatitis C is curable. Even slightly elevated liver enzymes need further examination].

Niederau C.

MMW Fortschr Med. 2008 Mar 27;150(13):26. German. No abstract available.

PMID:
18522352
16.

Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9.

Nguyen MH, Keeffe EB.

Rev Gastroenterol Disord. 2004;4 Suppl 1:S14-21. Review.

PMID:
15184820
17.

Further evolution of hepatitis C treatment: individualized therapy.

Smith JR, Herrera JL.

Am J Gastroenterol. 2000 Sep;95(9):2383. Review. No abstract available.

PMID:
11007249
18.

Treatment of chronic hepatitis C.

Bihl F, Negro F.

Minerva Med. 2009 Dec;100(6):459-65. Review.

PMID:
20010481
19.

Audit of state-funded antiviral treatment for chronic hepatitis C in Qatar.

John AK, Al KS, John A, Singh R, Derbala M.

East Mediterr Health J. 2010 Nov;16(11):1121-7.

PMID:
21218734
20.

Infectious disease. Despite setbacks, optimism on drugs for hepatitis C.

Cohen J.

Science. 2012 Sep 21;337(6101):1450-1. No abstract available.

PMID:
22997303
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk